Overseas expansion key for healthcare sector in 2019 and beyond: analysts
Having overseas entities will help firms manage in an increasingly competitive medical tourism market
Singapore
WITH some exceptions, the healthcare sector was not spared the trade tensions and uncertainty that dogged equity markets throughout 2018.
Going forward, cost pressures and macroeconomic headwinds are expected to moderate prospects in 2019, but the long-term view is rosier, especially for companies with overseas operations. Analysts project a positive outlook beyond 2019 when recent regional expansions for players such as IHH Healthcare Bhd and Singapore Medical Group (SMG) will start to yield results, if handled successfully.
TRENDING NOW
Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose
Brokers maintain ‘buy’ on CDL despite investor reservations over strategic review
Deal between tycoon friends sparks scrutiny of Philippine power sector
Hwa Seng Builder, two China companies win S$1.2 billion Tuas Road Viaduct phase two contracts